Start SIP in AJOONI
Start SIPPerformance
- Low
- ₹7
- High
- ₹7
- 52 Week Low
- ₹4
- 52 Week High
- ₹10
- Open Price₹7
- Previous Close₹7
- Volume399,474
Investment Returns
- Over 1 Month -8.68%
- Over 3 Month -15.67%
- Over 6 Month + 41%
- Over 1 Year + 23.9%
Smart Investing Starts Here Start SIP with Ajooni Biotech for Steady Growth!
Ajooni Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 49.8
- PEG Ratio
- 0.7
- Market Cap Cr
- 121
- P/B Ratio
- 2.8
- Average True Range
- 0.33
- EPS
- 0.14
- Dividend Yield
- 0
- MACD Signal
- -0.12
- RSI
- 31.54
- MFI
- 9.58
Ajooni Biotech Financials
Ajooni Biotech Technicals
EMA & SMA
Current Price
₹7.05
+
0.01
(0.14%)
- Bullish Moving Average 1
- Bearish Moving Average 15
- 20 Day
- ₹7.46
- 50 Day
- ₹7.66
- 100 Day
- ₹7.58
- 200 Day
- ₹7.08
Resistance and Support
7.1
- R3 7.44
- R2 7.34
- R1 7.20
- S1 6.96
- S2 6.86
- S3 6.72
Ajooni Biotech Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-13 | Quarterly Results | |
2024-08-16 | Others | To consider other business matters issue of equity shares of Rs. 2/- in the ratio of 1:1 @ premium of Rs. 3/-. |
2024-08-09 | Quarterly Results | |
2024-05-20 | Audited Results | |
2024-02-07 | Quarterly Results & Others | Other business matters. issue of equity shares of Rs. 2/- in the ratio of 1:1 @ premium of Rs. 3/-. |
Ajooni Biotech F&O
About Ajooni Biotech
- NSE Symbol
- AJOONI
- BSE Symbol
- Managing Director & CFO
- Mr. Jasjot Singh
- ISIN
- INE820Y01021
Similar Stocks to Ajooni Biotech
Ajooni Biotech FAQs
Ajooni Biotech share price is ₹7 As on 28 December, 2024 | 02:18
The Market Cap of Ajooni Biotech is ₹121.4 Cr As on 28 December, 2024 | 02:18
The P/E ratio of Ajooni Biotech is 49.8 As on 28 December, 2024 | 02:18
The PB ratio of Ajooni Biotech is 2.8 As on 28 December, 2024 | 02:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.